Weave (WEAV) Q4 2025: Specialty Medical Adds 29% of New Locations, Expanding Vertical TAM
Weave’s Q4 marked a pivotal expansion in the specialty medical vertical, now the company’s second largest by location count, driving a $7 billion increase in total addressable market (TAM). AI-powered front office automation and payments adoption are deepening customer reliance, while disciplined cost management is improving operating leverage. With omnichannel AI receptionist and CareCredit integration set for 2026, Weave signals a strategy built on vertical depth and recurring workflow ownership.
Summary
- Vertical Penetration Accelerates: Specialty medical became Weave’s second largest vertical, unlocking new TAM and growth vectors.
- AI Workflow Integration Deepens: Unified inbox and omnichannel AI receptionist rollout are making Weave indispensable for practice operations.
- Payments Ecosystem Expands: CareCredit partnership and surcharging tools position Weave for higher attach rates and stickier revenue streams.
Performance Analysis
Weave delivered consistent double-digit revenue growth and record gross margins, reflecting both operational discipline and expanding product adoption. Payments revenue outpaced overall company growth, benefiting from new features like bulk collections, surcharging, and automated reminders, and now contributes a growing share of high-margin revenue. Operating income reached its highest level to date, with margin expansion driven by cloud infrastructure efficiencies and the amortization of hardware assets.
Specialty medical emerged as Weave’s fastest growing vertical, accounting for the largest quarterly addition of new locations in company history and now representing the company’s second largest vertical by location count. Churn rates in new verticals improved as integration depth increased, and net revenue retention trends stabilized following the prior year’s price increases. Free cash flow improved at a faster rate than revenue, underscoring a balanced approach to growth and profitability.
- Margin Expansion Outpaces Revenue: Gross margin reached a record high, supported by product mix shift and infrastructure leverage.
- Churn and Retention Stabilize: Q4 churn returned to historical levels as onboarding and integration initiatives took hold.
- Upsell Opportunity Widens: Less than 2% penetration of new AI and insurance products in the base signals untapped expansion runway.
Weave’s results highlight a model that is scaling profitably, with strong liquidity and disciplined investment in growth levers that expand both vertical reach and product depth.
Executive Commentary
"Weave is the unified AI-powered patient communications and engagement platform purpose-built for small and medium-sized healthcare practices. We bring together AI agent and practice staff conversations across voice and text into unified workflows."
Brett White, Chief Executive Officer
"The growth in our product suite this year, including the acquisition of Trulark, expanded our estimated total addressable market by roughly $7 billion to an estimated $22 billion. We believe there is further TAM expansion on the horizon as we add capabilities to our AI receptionist."
Jason Christensen, Chief Financial Officer
Strategic Positioning
1. Specialty Medical Vertical Penetration
Specialty medical now represents Weave’s second largest vertical by location count, driven by targeted integrations and focused marketing investment. The company is currently concentrated on four of 29 possible specialties, with primary care, physical and occupational therapy, aesthetics, and med spa as initial footholds. This vertical’s low current penetration (about 1%) and high complexity create a durable long-term growth engine as more specialties are addressed and integration depth increases.
2. AI-Driven Workflow Ownership
Weave’s unified platform is evolving into an operational system of record for SMB healthcare practices, consolidating communications, scheduling, billing, and payments across channels. The rollout of omnichannel AI receptionist and unified inbox capabilities—integrating both AI agent and staff interactions—positions Weave to automate high-friction administrative workflows. This deepens reliance, increases switching costs, and enables Weave to capture a larger share of the labor budget historically allocated to front office staff.
3. Payments Ecosystem Expansion
Payments revenue grew at more than twice the company’s overall rate, aided by new features like surcharging and automated reminders. The CareCredit partnership extends Weave’s reach into patient financing, making the payments suite more attractive and embedded. As practices seek to streamline collections and offer financing, Weave’s integrated solution becomes more central to daily operations and patient experience.
4. Product and Go-To-Market Investments
Disciplined investment in product engineering and go-to-market (GTM) capacity is driving both innovation and sales efficiency. The transition to a sales development representative (SDR) and account executive (AE) model has begun to yield efficiency gains, while targeted sales and marketing spend in specialty medical and mid-market segments is generating pipeline growth. The company’s approach to vertical expansion is stepwise, focusing on integration depth and churn reduction before scaling to new segments.
5. Durable Data and Compliance Moat
Weave’s ownership of the telephony stack, deep practice management system (PMS) integrations, and compliance with HIPAA and PCI standards create a defensible moat in a highly regulated market. The company’s scale and domain expertise allow for high accuracy in AI-driven workflows without exposing protected health information (PHI), a critical differentiator as buyers become more sensitive to security and reliability concerns.
Key Considerations
Weave’s quarter illustrates a business at the intersection of vertical SaaS, payments, and AI-powered automation, with strategic bets on workflow integration and vertical depth. The company’s ability to expand its TAM, deepen product adoption, and maintain cost discipline will shape its trajectory in 2026 and beyond.
Key Considerations:
- Vertical Expansion Model: Stepwise approach to new specialties allows for churn reduction and higher average revenue per location as integration depth matures.
- AI Monetization Path: Licensing by location and consumption, not seat, enables Weave to capture labor budget as AI automates more workflows.
- Retention Dynamics: Net revenue retention is pressured by heavy initial product adoption, but new products like Trulark and insurance eligibility open upsell runway.
- Payments as Sticky Anchor: New features and partnerships (e.g., CareCredit) deepen payments integration, raising switching costs and customer lifetime value.
- Operational Leverage: Gross margin and free cash flow gains reflect successful cost management and product mix optimization.
Risks
Weave faces risks from competitive encroachment, particularly as horizontal AI providers target healthcare workflows. Churn in new verticals remains elevated until integration depth matures, and heavy initial product adoption can limit near-term upsell opportunities. Regulatory compliance and data security are table stakes, and any misstep could erode trust in a highly sensitive end market. Macroeconomic headwinds or changes in healthcare reimbursement could impact customer budgets and adoption velocity.
Forward Outlook
For Q1 2026, Weave guided to:
- Total revenue of $64.2 million to $64.8 million
- Operating income of $1 million to $2 million, with expected seasonal expense increases
For full-year 2026, management raised expectations:
- Total revenue of $273 million to $276 million
- Non-GAAP operating income of $8 million to $12 million
Management highlighted several factors that will shape 2026:
- Omnichannel AI receptionist and unified inbox general availability in the first half, with broader AI workflow automation in the second half
- Continued margin improvement and increased operating leverage as prior investments yield returns
Takeaways
Weave’s Q4 confirms the company’s ability to execute on vertical expansion, deepen workflow ownership, and drive profitable growth through disciplined investment and product innovation.
- Vertical Depth Drives TAM and Growth: Specialty medical’s rise to second largest vertical and record location additions underscore the effectiveness of integration-led expansion.
- AI and Payments Fuel Stickiness: Unified workflows and embedded payments increase reliance, raise switching costs, and set the stage for future upsell and monetization.
- Watch for AI Monetization and Retention Trends: The pace of AI adoption and upsell penetration will determine Weave’s ability to expand net revenue retention and capture incremental share of wallet in 2026.
Conclusion
Weave’s Q4 2025 results reflect a company scaling profitably, with expanding vertical reach, deepening workflow integration, and a disciplined approach to AI and payments innovation. Execution on vertical SaaS and automation is translating into durable customer value and a growing financial foundation for 2026.
Industry Read-Through
Weave’s vertical SaaS playbook and AI-powered workflow automation strategy signal a broader shift in healthcare IT, where domain expertise, deep integrations, and secure data handling are critical to winning SMB providers. Payments integration and labor automation are becoming table stakes, and platforms that own the full patient-provider interaction are best positioned to capture share. Competitors lacking regulatory compliance or vertical depth will struggle to match retention and upsell economics. This quarter’s results reinforce the value of owning the operational “system of work” in complex, regulated end markets—a lesson applicable across vertical SaaS, fintech, and healthtech sectors.